4.5 Editorial Material

RNA biology of angiogenin: Current state and perspectives

期刊

RNA BIOLOGY
卷 14, 期 2, 页码 171-178

出版社

TAYLOR & FRANCIS INC
DOI: 10.1080/15476286.2016.1272746

关键词

Angiogenin; ribonuclease; ribosome; tiRNAs; translation; tRNA

资金

  1. National Institutes of Health [GM111700, CA168872, NS094918, F32GM119283]
  2. NATIONAL CANCER INSTITUTE [R01CA168872] Funding Source: NIH RePORTER
  3. NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM119283] Funding Source: NIH RePORTER
  4. NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS094918] Funding Source: NIH RePORTER

向作者/读者索取更多资源

Angiogenin (ANG) is a secreted ribonuclease best known for its ability to promote formation of blood vessels. Extensive research over many years has elucidated its structure and biophysical properties, although our knowledge of molecular mechanisms underlying ANG-associated biologic processes remains limited. Intriguingly, many of processes require the ribonuclease activity of ANG, thus highlighting the importance of identifying and characterizing RNA targets and intermediates of ANG-mediated endonucleolytic cleavage. While ANG demonstrates ribonuclease activity toward many RNA substrates in vitro, specific target of ANG, namely mature tRNA, was only recently identified in vivo. ANG-mediated tRNA cleavage is an unorthodox manner of generating non-coding RNAs with diverse biologic activities. In addition, the ribonuclease activity of ANG has been reported to be crucial for rRNA transcription. Here we critically discuss various aspects of ANG biology related to its RNase activity and discuss areas in need of further investigation.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据